L Akard

798 total citations
19 papers, 457 citations indexed

About

L Akard is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, L Akard has authored 19 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in L Akard's work include Hematopoietic Stem Cell Transplantation (8 papers), Immunotherapy and Immune Responses (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). L Akard is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Immunotherapy and Immune Responses (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). L Akard collaborates with scholars based in United States, Netherlands and France. L Akard's co-authors include Guido Tricot, Bruce J. Roth, Stephen D. Williams, Robert J. Goulet, S N Wolff, Craig R. Nichols, Patrick J. Loehrer, Ronald Hoffman, Koen van Besien and J Jansen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Transfusion.

In The Last Decade

L Akard

19 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Akard United States 9 212 204 130 117 88 19 457
John W. McBroom United States 13 84 0.4× 146 0.7× 33 0.3× 106 0.9× 17 0.2× 18 546
Harry Fisher United States 8 155 0.7× 44 0.2× 58 0.4× 136 1.2× 40 0.5× 11 442
R Rondinone Italy 10 29 0.1× 52 0.3× 51 0.4× 48 0.4× 57 0.6× 19 366
J.R. Germà Spain 12 385 1.8× 58 0.3× 100 0.8× 142 1.2× 7 0.1× 27 520
Mario Ghosn France 10 150 0.7× 29 0.1× 64 0.5× 55 0.5× 17 0.2× 39 305
Byung‐Kiu Park South Korea 10 102 0.5× 46 0.2× 27 0.2× 92 0.8× 17 0.2× 24 362
Lothar Kanz Germany 5 77 0.4× 35 0.2× 17 0.1× 160 1.4× 180 2.0× 5 380
Serena Martinelli Italy 12 87 0.4× 125 0.6× 28 0.2× 176 1.5× 27 0.3× 32 400
Yacov Goshen Israel 13 41 0.2× 56 0.3× 119 0.9× 162 1.4× 13 0.1× 18 443
H Schefer Switzerland 6 78 0.4× 21 0.1× 38 0.3× 54 0.5× 21 0.2× 14 336

Countries citing papers authored by L Akard

Since Specialization
Citations

This map shows the geographic impact of L Akard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Akard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Akard more than expected).

Fields of papers citing papers by L Akard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Akard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Akard. The network helps show where L Akard may publish in the future.

Co-authorship network of co-authors of L Akard

This figure shows the co-authorship network connecting the top 25 collaborators of L Akard. A scholar is included among the top collaborators of L Akard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Akard. L Akard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Caimi, Paolo F., Tycel Phillips, M. S. Wertheim, et al.. (2017). ONGOING PHASE 1/2 STUDY OF INCB050465, A SELECTIVE PI3Kδ INHIBITOR, FOR THE TREATMENT OF PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B‐CELL MALIGNANCIES (CITADEL‐101). Hematological Oncology. 35(S2). 268–268. 1 indexed citations
2.
Bollu, Vamsi, Alfonso Quintás‐Cardama, Maria Flamm, et al.. (2011). PCN12 RESOURCE UTILIZATION AND PERCEPTIONS OF MAJOR MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML): RESULTS OF A DELPHI PANEL STUDY. Value in Health. 14(3). A156–A157. 5 indexed citations
3.
Cortes, Jörge E., Carole B. Miller, J. H. Lipton, et al.. (2011). Open-label study evaluating change in chronic low-grade (LG) non-hematologic (heme) adverse events (AEs) in Philadelphia positive (Ph+) CML-CP patients (pts) switched from imatinib (IM) to nilotinib (NL).. Journal of Clinical Oncology. 29(15_suppl). 6615–6615. 1 indexed citations
4.
Jansen, J, et al.. (2008). Slow platelet recovery after PBPC transplantation from unrelated donors. Bone Marrow Transplantation. 43(6). 499–505. 8 indexed citations
5.
Jansen, J, James Thompson, Michael J. Dugan, et al.. (2004). Impaired PBPC collection in patients with myeloma after high-dose melphalan. Cytotherapy. 6(5). 498–504. 9 indexed citations
6.
Jansen, J, et al.. (1999). Hematopoietic growth factor after autologous peripheral blood transplantation: comparison of G-CSF and GM-CSF. Bone Marrow Transplantation. 23(12). 1251–1256. 12 indexed citations
7.
Harvey, Kevin, Nancy Higgins, L Akard, et al.. (1997). Lineage Commitment of HLA-DR/CD38-Defined Progenitor Cell Subpopulations in Bone Marrow and Mobilized Peripheral Blood Assessed by Four-Color Immunofluorescence. Journal of Hematotherapy. 6(3). 243–252. 7 indexed citations
8.
Chang, Qing, Kevin Harvey, L Akard, et al.. (1997). Counterflow centrifugal elutriation as a method of T cell depletion may cause loss of immature CD34+ cells. Bone Marrow Transplantation. 19(11). 1145–1150. 5 indexed citations
9.
Chang, Qing, Kevin Harvey, L Akard, et al.. (1997). Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation.. PubMed. 25(5). 423–31. 5 indexed citations
10.
Jansen, J, L Akard, James P. Thompson, et al.. (1995). Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation.. PubMed. 15(2). 271–8. 12 indexed citations
11.
Cui, Yukun, Kevin Harvey, L Akard, et al.. (1994). Regulation of neutrophil responses by phosphotyrosine phosphatase.. The Journal of Immunology. 152(11). 5420–5428. 24 indexed citations
12.
Jansen, J, et al.. (1994). Immunomagnetic CD8 depletion.. PubMed. 389. 551–6. 3 indexed citations
13.
Cui, Yujun, Denis English, Rafat A. Siddiqui, et al.. (1994). Parallel up-regulation of CD11B and CD45 on neutrophilic leukocytes exposed to soluble factors of oral pathogens.. PubMed. 33(1). 45–54. 3 indexed citations
14.
Jansen, J, et al.. (1992). Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.. PubMed. 377. 405–10. 1 indexed citations
15.
Besien, Koen van, C R Nichols, Guido Tricot, et al.. (1990). Characteristics of engraftment after repeated autologous bone marrow transplantation.. PubMed. 18(7). 785–8. 2 indexed citations
16.
Broun, E. Randolph, Guido Tricot, L Akard, et al.. (1990). Treatment of refractory lymphoma with high dose cytarabine, cyclophosphamide and either TBI or VP-16 followed by autologous bone marrow transplantation.. PubMed. 5(5). 341–4. 9 indexed citations
17.
English, Denis, et al.. (1989). Semiautomated processing of bone marrow grafts for transplantation. Transfusion. 29(1). 12–16. 44 indexed citations
18.
Nichols, Craig R., Guido Tricot, Stephen D. Williams, et al.. (1989). Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.. Journal of Clinical Oncology. 7(7). 932–939. 258 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026